Skip to main content
. 2021 Oct 20;11:749753. doi: 10.3389/fonc.2021.749753

Figure 1.

Figure 1

Diagnostic value of LINC00511, miR-185-3p, and miR-301a-3p. (A) Expression levels of targets in BC patients. LINC00511 and miR-301a-3p were significantly overexpressed, and on the contrary, miR-185-3p was reciprocally downregulated in BC patients, (B) receiver operating characteristic (ROC) curves for the investigated biomarkers, (C) Negative Likelihood Ratios (−LR) of the estimated markers; estimated % decrease in probability is large (45%) when −LR = 0.1, moderate (30%) when −LR = 0.1–0.2, and small (15%) when −LR = 0.2–0.5. [All values were obtained using MedCalc software (https://www.medcalc.org/calc). Data were plotted graphically using GraphPad prism software]. ****p < 0.0001. ***p < 0.001. **p < 0.01. *p < 0.05. RQ, relative expression; BC, breast cancer.